Thursday, 30 July 2026🔴 Startups: Equal1's Bell-1 quantum chip raises $60 million
Startups & Founders

Equal1 Has Built Ireland's First Quantum Processing Unit — and Just Raised $60 Million to Deploy It

Dublin-based Equal1 has produced Bell-1, a commercially deployable quantum chip that works at room temperature and fits into existing high-performance computing infrastructure.

Business Pulse Editorial
Startups & Founders · 2 min read · 30 July 2026

A Chip That Rewrites the Rules

In October 2025, a Dublin-based startup called Equal1 emerged from stealth to announce something that very few people outside the quantum computing community had been expecting from an Irish company: Bell-1, Ireland's first homegrown quantum processing unit. Bell-1 is not a research prototype or a university laboratory project. It is a commercially deployable quantum chip, designed to operate at room temperature rather than in the cryogenic cooling systems that most quantum computers require, and built to integrate into existing high-performance computing infrastructure rather than requiring entirely new facilities. That combination — practical, deployable, integrable — is precisely what makes Equal1's approach distinctive in a sector where many of the headline breakthroughs remain years away from real-world application.

The $60 Million Round

In January 2026, Equal1 announced a $60 million funding round to support the wider deployment of Bell-1 — one of the largest single funding events in the Irish startup ecosystem in the first half of the year and a clear signal of the seriousness with which the international investment community is treating the company's technology. The funding round was led by Ireland Strategic Investment Fund, with participation from Atlantic Bridge, the European Innovation Council Fund, Matterwave Ventures, Enterprise Ireland, Elkstone and TNO Ventures.

The breadth of the investor base is instructive. The Ireland Strategic Investment Fund — a sovereign investment vehicle — alongside the European Innovation Council Fund signals institutional confidence in Equal1's technology at the level of national and European strategic investment. Atlantic Bridge, the most active Irish deeptech investor with a track record across multiple successful enterprise technology exits, provides commercial validation. TNO Ventures, the investment arm of the Netherlands Organisation for Applied Scientific Research, adds a European research credibility dimension that reflects Equal1's positioning at the intersection of fundamental science and commercial application.

The European Space Agency Partnership

Among the deployment destinations for Bell-1 confirmed at the time of the January raise was the European Space Agency's Phi-lab in Italy — one of the most demanding and technically rigorous deployment environments available for a new computing technology and a partnership that simultaneously validates the chip's performance credentials and places Equal1 within the European space technology ecosystem. The Phi-lab connection is not merely a prestigious reference site. It is a live deployment of Bell-1 in an environment where computational performance requirements are extreme and the tolerance for technology that does not deliver is essentially zero.

The funding will also enable Equal1 to advance its roadmap towards "millions" of on-chip qubits, scale manufacturing — a trajectory that, if achieved, would represent a fundamental step change in the computational power available to the industries Equal1 is targeting: financial services, pharmaceutical drug discovery, logistics optimisation, materials science and cryptography.

The Wider Context: Ireland's Deeptech Moment

Equal1's emergence as a globally significant quantum computing company from a Dublin base reflects a broader shift in the Irish startup ecosystem toward deeptech — companies building at the frontier of fundamental science and engineering rather than software applications sitting on top of existing infrastructure. The standout companies are tied to hard business needs: Aerska in biotech, Forge Robotics in industrial automation, Bronto in data systems for the AI era, and Akara in hospital tech. Equal1 fits squarely within this pattern: a company whose competitive advantage is a proprietary technology breakthrough rather than a faster or cheaper version of something that already exists.

The support ecosystem for deeptech in Ireland has also matured significantly in 2025 and 2026. Enterprise Ireland invested over €30 million in Irish startups last year, with €23 million approved in equity funding for High Potential Startups and €9.55 million allocated through the Pre-Seed Start Fund. For a company at Equal1's stage, the availability of patient, mission-aligned capital from Enterprise Ireland alongside international venture backing is the combination that allows a deeptech company to develop its technology without the commercial pressure to commercialise prematurely.

The Bottom Line

Equal1 has done something genuinely rare in Irish technology history — built a proprietary hardware technology at the frontier of global science and attracted $60 million in international institutional capital to deploy it. Bell-1's room-temperature operation and integration into existing high-performance computing infrastructure gives it a practical advantage that many quantum computing approaches lack. The European Space Agency deployment and the investor lineup confirm that this is not a speculative bet but a live technology with a credible and funded path to scale.